Mepsgen
Business Services · South Korea · 11-50 Employees
View Company Info for Free
Overview
Headquarters
7f Hanyang Tower 12 BEOBWON-RO-11-GIL, S...Website
www.mepsgen.comRevenue
<$5 MillionIndustry
About Mepsgen
Mepsgen Org Chart
Is Mepsgen your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check out if Mepsgen is spiking on competitors!
Congratulate Masked Content for being promoted to Masked Content at Mepsgen
Product Launch: Get notified when Mepsgen launches new products
Mepsgen, which may be a good buyer, showed buying intent in Masked Content Topic
Funding: Get notified immidiatlly once Mepsgen has new funding data
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Click to see if Mepsgen had a recent Job posting/layoffs
Website visits: Recent activity has been detected on your website
Earning: See what the market has to say on Mepsgen recently announced quarterly report
Check if Mepsgen has recently received funding, and reach out quickly before it becomes old news!
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find more new buyers
Company Profile Activity
Activity Insights
Mepsgen is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Mepsgen is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Mepsgen.
Mepsgen Tech Stack
A closer look at the technologies used by Mepsgen
Mepsgen News & Media
Top Business Services Companies
Frequently Asked Questions Regarding Mepsgen
MEPSGEN is a biotechnology company specializing in the development and research services of biopharmaceuticals through its innovative microphysiological systems and nanoparticle production technologies. The company offers a range of products including 3D and 2D tissue barrier chips, organ-on-a-chip models, and automated synthesis systems. MEPSGEN's... Read More